By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Asuragen, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-651-0191 Fax: 512-721-4859



Start Up

Company News
Asuragen, Inc. Launches Amplidex PCR/CE FMR1 Reporter*, A Fully Automated Software Solution For Accurate Sizing Of The FMR1 CGG Repeat Region 11/5/2015 11:06:11 AM
Asuragen, Inc. To Present At Upcoming 2015 Association For Molecular Pathology Annual Meeting In Austin, TX 11/3/2015 11:05:27 AM
Asuragen, Inc. To Collaborate With Illumina (ILMN) On Companion Diagnostics Development 9/9/2015 11:05:07 AM
Asuragen, Inc. Launches The Quantidex Pan Cancer Kit, A Workflow Solution For Targeted Next-Generation Sequencing 7/8/2015 8:12:00 AM
Asuragen, Inc. Announces Launch Of Highly Sensitive CE-IVD BCR-ABL Assay At The European Hematology Association Annual Congress 6/11/2015 2:18:44 PM
Asuragen, Inc. To Present Innovations In Fragile X Testing At Upcoming American College Of Medical Genetics And Genomics (ACMG) Annual Clinical Genetics Meeting 3/24/2015 12:20:14 PM
Asuragen, Inc. To Join Leading UK Cancer Research Consortium To Develop Mirna Based Sequencing Tests For Early Detection And Screening Of Cancer 1/12/2015 11:09:08 AM
Asuragen, Inc. Launches The Quantidex™ DNA Assay To Improve The Accuracy Of Next-Generation Sequencing 11/11/2014 11:10:37 AM
Asuragen, Inc. To Present At Upcoming Association For Molecular Pathology Annual Meeting In National Harbor, MD 11/11/2014 9:38:33 AM
Asuragen, Inc.’s Xpansion Interpreter® Test Study Of 1,040 Transmissions Of Fragile X Alleles Reveals Personalized Risks For Expansion From Parent To Child 9/17/2014 11:03:45 AM